Esperion Therapeutics (ESPR) Profit Margin (2019 - 2026)
Esperion Therapeutics (ESPR) profit margin from Mar 31, 2019 to Mar 31, 2026. The current Esperion Therapeutics (ESPR) profit margin is -31.46%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Esperion Therapeutics (ESPR)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -5.63% | -63.87% |
| 2024 | -15.57% | -91.34% |
| 2023 | -179.88% | -41.90% |
| 2022 | -309.61% | -9.74% |
| 2021 | -343.03% | +443.76% |
| 2020 | -63.09% | -3.67% |
| 2019 | -65.49% | -99.06% |
| 2019 | -6977.55% | +26.12% |
| 2019 | -5532.65% | -9307.58% |
| 2019 | 60.09% | N/A |
Comparison Esperion Therapeutics (ESPR) profit margin with competitors
Esperion Therapeutics (ESPR) profit margin is -31.46%.